---

---

results   crawled time : 12:20   

save search

---

YS Biopharma Announces Results of Extraordinary General Meeting and Responds to False Statements about the Meeting
Published: 2024-02-18 (Crawled : 12:20) - prnewswire.com
YS | News | $0.7013 -17.98% -21.92% 420K |

n/a

| Email alert Add to watchlist
biopharma meeting results

---

Intchains Group Limited to Report Unaudited Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024
Published: 2024-02-18 (Crawled : 12:20) - globenewswire.com
ICG | $8.17 -0.61% 100 |

n/a

| Email alert Add to watchlist
report year group financial results

---

Piramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2024
Published: 2023-10-28 (Crawled : 12:20) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| Email alert Add to watchlist
fy2024 pharma results

---

Ascendis Pharma Presents Results from Long-Term enliGHten Trial of TransCon™ hGH in Pediatric Growth Hormone Deficiency
Published: 2023-09-23 (Crawled : 12:20) - globenewswire.com
ASND | $140.19 -0.5% -0.5% 270K |

Health Technology

| Email alert Add to watchlist
pharma trial results growth hormone

---

Mineralys Therapeutics Presents Target-HTN Phase 2 Trial Results in Late-Breaking Science Session at 2023 AHA Hypertension Scientific Sessions
Published: 2023-09-10 (Crawled : 12:20) - globenewswire.com
MLYS M | $11.32 5.3% 5.04% 100K |

| Email alert Add to watchlist
sessions hypertension trial therapeutics results phase 2

---

Mineralys Therapeutics Announces JAMA Publication of Full Target-HTN Phase 2 Trial Results for Lorundrostat in Uncontrolled and Treatment-Resistant Hypertension
Published: 2023-09-10 (Crawled : 12:20) - globenewswire.com
MLYS M | $11.32 5.3% 5.04% 100K |

| Email alert Add to watchlist
publication hypertension trial therapeutics results

---

BridgeBio presents detailed positive results from Phase 3 ATTRibute-CM study of acoramidis for patients with transthyretin amyloid cardiomyopathy (ATTR-CM) at European Society of Cardiology Congress 2023
Published: 2023-08-27 (Crawled : 12:20) - globenewswire.com
BBIO | $24.74 -0.84% -0.85% 2M |

Health Technology

| Email alert Add to watchlist
positive cardiology results study

---

BOS Reports Financial Results for the Second Quarter of the Year 2023
Published: 2023-08-22 (Crawled : 12:20) - globenewswire.com
BOSC | $2.79 -1.4% -1.42% 18K |

Electronic Technology

| -21.47% | O: 3.67% H: 0.0% C: -1.09%
year financial results

---

Rail Vision Announces Second Quarter 2023 Financial Results
Published: 2023-08-18 (Crawled : 12:20) - globenewswire.com
RVSN | $1.04 -5.46% -5.77% 600K |

n/a

| -71.05% | O: -4.25% H: 11.6% C: 4.65%
financial results

---

ToughBuilt Industries to Report Second Quarter 2023 Financial Results on August 22, 2023
Published: 2023-08-17 (Crawled : 12:20) - globenewswire.com
TBLT | $2.26 -1.74% -1.77% 54K |

Consumer Non-Durables

| -87.14% | O: 2.61% H: 1.74% C: -2.58%
report financial results

---

Nanox Announces Second Quarter of 2023 Financial Results and Provides Business Update
Published: 2023-08-17 (Crawled : 12:20) - globenewswire.com
NNOX | $8.62 -4.96% -5.22% 1M |

Health Technology

| -4.87% | O: 7.3% H: 12.16% C: -2.06%
business update financial results

---

Semantix Announces 2Q 2023 Financial Results
Published: 2023-08-17 (Crawled : 12:20) - globenewswire.com
STIX | $0.3 1.7% 110K |

n/a

| -82.66% | O: 6.36% H: 0.0% C: -5.29%
financial results

---

Qualigen Therapeutics, Inc. Reports Financial Results and Corporate Update for Quarter Ending June 30, 2023
Published: 2023-08-15 (Crawled : 12:20) - globenewswire.com
QLGN | $0.301 -3.43% -3.55% 30K |

Health Technology

| -69.52% | O: -1.9% H: 6.8% C: 6.14%
update financial results

---

Ascendis Pharma to Report Second Quarter 2023 Financial Results and Provide Business Update on September 5, 2023
Published: 2023-08-15 (Crawled : 12:20) - globenewswire.com
ASND | $140.19 -0.5% -0.5% 270K |

Health Technology

| 54.08% | O: 1.68% H: 2.74% C: 0.0%
pharma report business update financial results

---

Xalles Announces Q2 2023 Results and Expands Portfolio With Trio of Strategic Acquisitions
Published: 2023-08-15 (Crawled : 12:20) - globenewswire.com
XALL | $0.0012 0.0% 4.2M |

Real Estate and Rental and Leas...

| -63.33% | O: -10.0% H: 18.52% C: 18.52%
acquisitions results

---

Cellectar Reports Financial Results for Second Quarter 2023 and Provides a Corporate Update
Published: 2023-08-14 (Crawled : 12:20) - globenewswire.com
CLRB | $3.02 -0.66% -0.66% 810K |

Health Technology

| 89.37% | O: -1.88% H: 6.37% C: 3.82%
update financial results

---

BTCS Reports Q2 2023 Results
Published: 2023-08-14 (Crawled : 12:20) - globenewswire.com
CRCW | News | $0.0015 27.78% 8.5M |

Information

| 13.33% | O: 0.0% H: 0.0% C: -1.0%
BTCS | $1.42 -2.07% -2.11% 32K |

Manufacturing

| 35.24% | O: 0.0% H: 1.87% C: 0.95%
results

---

Eloxx Pharmaceuticals Reports Second Quarter 2023 Financial and Operating Results and Provides Business Update
Published: 2023-08-14 (Crawled : 12:20) - globenewswire.com
ELOX | $0.94 -51.57% 93K |

Health Technology

| -83.16% | O: 5.05% H: 20.04% C: 14.83%
business update pharmaceuticals financial results

---

Nemaura Medical Reports Fiscal First Quarter 2024 Results and Provides Business Update
Published: 2023-08-14 (Crawled : 12:20) - globenewswire.com
NMRD | $0.0798 -28.78% 28K |

Health Technology

| -89.74% | O: 19.29% H: 4.23% C: -14.37%
business update medical results

---

ContraFect Reports Second Quarter 2023 Financial Results and Provides Business Update
Published: 2023-08-14 (Crawled : 12:20) - globenewswire.com
CFRX | $0.05 0.0% 910K |

Health Technology

| -94.76% | O: 4.71% H: 0.0% C: -4.01%
business update financial results

---

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M |

Finance

EGOX | $0.0515 43.06% 30.1% 330M |

OLB 4 | $0.33 -14.95% 25.53% 840K |

Technology Services

NVFY | $2.77 31.28% 23.83% 33M |

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M |

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M |

Distribution Services

INSG | $3.03 25.21% 20.13% 330K |

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K |

Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M |

ASNS | $0.828 21.75% 17.86% 18K |

---

Your saved searches

---